Novavax (NVAX) Reports Q4 Loss, Misses Revenue Estimates
1/3 00:05
Novavax (NVAX) came out with a quarterly loss of $11.18 per share versus the Zacks Consensus Estimate of a loss of $1.43. This compares to loss of $2.70 per share a year ago. These figures are adjusted for non-recurring items....